Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells.
Li M, Zhong A, Wu Y, Sidharta M, Beaury M, Zhao X, Studer L, Zhou T
Nat Commun. 2022 Oct 27;13(1):6354. doi: 10.1038/s41467-022-34045-7.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
196582pCMV-PE2-p53DDMammalian expression of SpCas9 prime editor 2 with P2A-p53DD
199267pEF_PE2Mammalian expression of SpCas9 prime editor 2 under EF1α promoter
199271pegRNA-GBA-10pegRNA used to induce GBA (c. 1226 A > G) mutation
199272pegRNA_LRRK2-3pegRNA used to induce LRRK2 (c. 6055 G > A) mutation
199273pegRNA_LMNA-1pegRNA used to induce LMNA (c.1824C > T) mutation
199274pegRNA_GBA-4pegRNA used to correct GBA (c. 1226 A > G) mutation
199275pegRNA_LMNA_CR-2-5pegRNA used to correct LMNA (c.1824C > T) mutation
199276Lsg-GBA-1 + 2nicking sgRNA to induce or correct GBA (c. 1226 A > G) mutation using PE3
199277Lsg-LRRK2-1nicking sgRNA to induce LRRK2 (c. 6055 G > A) mutation using PE3
199278Lsg-LMNA-1 + 2nicking sgRNA to induce LMNA (c.1824C > T) mutation using PE3

Antibodies from Article